Verthermia
San Diego, US · Founded 2014 · California corporation
Verthermia develops HEATT (Hyperthermic Extracorporeal Applied Tumor Therapy), a whole-body hyperthermia treatment that heats a patient's blood in an external circuit to raise body temperature and target cancer cells, combined with dialysis to rebalance body chemistry. The therapy is used to treat cancers and other diseases and is administered in a hospital operating room setting.
Founders & leadership
SL
Stephen Lee ScottExecutive
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2016
▶$250KraisedJan 2017 · 8 investors · Other Health CareRule 506(b)
▶$250KraisedJan 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Lee ScottExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- Minimum investment
- $10K
- Sales commissions
- $25K
- Proceeds to insiders
- $100K
- Placement agents
- Cova Capital Partners
- First sale
- Nov 2016
- Incorporated
- Corporation, California, 2014
- Federal exemptions
- 06b, 04.2
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Verthermia for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Verthermia do?
- Verthermia develops HEATT (Hyperthermic Extracorporeal Applied Tumor Therapy), a whole-body hyperthermia treatment that heats a patient's blood in an external circuit to raise body temperature and target cancer cells, combined with dialysis to rebalance body chemistry. The therapy is used to treat cancers and other diseases and is administered in a hospital operating room setting.
- How much funding has Verthermia raised?
- Verthermia has disclosed $250K raised across 1 round.
- Where is Verthermia headquartered?
- Verthermia is headquartered in San Diego, US.